133
26
2
37
1
Cat. No. | Product Name | ||
---|---|---|---|
L2194 | 抗结直肠癌化合物库 | 1545 compounds | |
1545 种与结直肠癌相关的化合物,可以用于高通量和高内涵筛选; | |||
L2196 | 抗卵巢癌化合物库 | 1867 compounds | |
1867 种与卵巢癌相关的化合物,可以用于抗卵巢癌药物研发和药理研究 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T9582 |
CLEFMA
|
NF-κB | NF-κB |
CLEFMA 是一种姜黄素,抑制肿瘤生长与 NF-κB 调节的抗炎和抗转移作用有关,具有抗肿瘤活性。 | |||
T8310 |
MMP-9-IN-1
|
MMP | Proteases/Proteasome |
MMP-9-IN-1 是特异性的基质金属蛋白酶-9 抑制剂,选择性靶向 MMP-9 的血红素域,对其他 MMP 无影响。 | |||
T1855 |
ZCL278
ZCL 278 |
CDK; Ras | Cell Cycle/Checkpoint; GPCR/G Protein; MAPK |
ZCL278 是一种选择性 Cdc42 GTPase 抑制剂,与Cdc42结合,Kd 为 11.4 μM。 | |||
T10297L |
AMG 487
|
CXCR | Autophagy; GPCR/G Protein; Immunology/Inflammation |
AMG 487 是可口服的选择性趋化因子受体3拮抗剂,对 I-IP-10、I-ITAC 和 MIG 的 IC50 值分别为 8、15 和 36nM。 | |||
T8217 |
Enzalutamide carboxylic acid
|
Androgen Receptor; Drug Metabolite | Endocrinology/Hormones; Metabolism |
Enzalutamide carboxylic acid 是 Enzalutamide 非活性代谢物。Enzalutamide 是雄激素受体 (AR) 拮抗剂。 | |||
T22263 |
Bavdegalutamide
ARV-110 |
Androgen Receptor | Endocrinology/Hormones |
Bavdegalutamide (ARV-110) 是一种雄激素受体 (AR) 的 PROTAC 降解剂。 Bavdegalutamide 可用于前列腺癌的研究。 Bavdegalutamide 具有口服活性和选择性,并促进 AR 的泛素化和降解。 | |||
T27730 |
KGP94
KGP-94,KGP 94 |
Cysteine Protease | Proteases/Proteasome |
KGP94 是一种有效的、选择性的和竞争性的溶酶体内肽酶抑制剂。 | |||
T12695 |
RBN-2397
|
PARP | Chromatin/Epigenetic; DNA Damage/DNA Repair |
RBN-2397 是一种有效的、选择性的、具有口服活性的跨物种 NAD+ 竞争性 PARP7 抑制剂,IC50 小于 3 nM。它选择性结合 PARP7 ,Kd 为0.001 μM,可恢复干扰素 I 型信号转导,有用于晚期或转移性实体肿瘤的研究潜力。 | |||
T8327 |
ONO-7475
|
Trk receptor; TAM Receptor | Tyrosine Kinase/Adaptors |
ONO-7475 是一种选择性的、有效的、具有口服活性的Axl/Mer 抑制剂。它使 AXL 过表达的EGFR 突变型 NSCLC 细胞对 EGFR-TKIs 敏感,抑制耐药细胞的产生和耐药性的维持。它与 Osimertinib 联合使用,具有用于 EGFR 突变非小细胞肺癌的潜力。 | |||
T12006 |
Metarrestin
ML246 |
DNA/RNA Synthesis | Cell Cycle/Checkpoint; DNA Damage/DNA Repair |
Metarrestin (ML246) 是一种口服有效的选择性核仁周区室 (PNC) 抑制剂,可有效抑制转移。Metarrestin 破坏核仁结构并抑制 RNA 聚合酶 (Pol) I 转录,部分是通过与翻译延伸因子 eEF1A2 的相互作用。 | |||
T1120 |
Dacarbazine
Imidazole Carboxamide,达卡巴嗪,DTIC-Dome |
Apoptosis; Nucleoside Antimetabolite/Analog; DNA/RNA Synthesis | Apoptosis; Cell Cycle/Checkpoint; DNA Damage/DNA Repair |
Dacarbazine (DTIC-Dome) 是一种抗肿瘤剂,对黑色素瘤具有显着的活性。 | |||
T5125 |
LY3200882
|
TGF-beta/Smad | Stem Cells |
LY3200882 是一种高度选择性的、口服活性的、具有 ATP 竞争性的 TGF-β 受体 1 型 (ALK5) 抑制剂(IC50:38.2 nM)。它能够抑制多种促肿瘤活性,可用作免疫调节剂。 | |||
T13687 |
Eribulin mesylate
B1939 mesylate,甲磺酸艾日布林,ER-086526 mesylate,E7389 mesylate |
Apoptosis; Others; Microtubule Associated | Apoptosis; Cytoskeletal Signaling; Others |
Eribulin mesylate (E7389 mesylate) 是一种靶向微管的抗癌剂,通过结合微管蛋白和微管来抑制癌细胞的增殖,可研究转移性乳腺癌。 | |||
T22450 |
Tyrphostin B44, (+) enantiomer
酪氨酸磷酸化抑制剂AG 835 |
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Tyrphostin B44, (+) enantiomer 是一种表皮生长因子受体 (EGFR) 激酶抑制剂,IC50 为 0.86 μM,活性低于 (-) 对映体。 | |||
T14953 |
Chloroquinoxaline sulfonamide
NSC-339004,Chloroquinoxaline |
Topoisomerase | DNA Damage/DNA Repair |
Chloroquinoxaline sulfonamide (Chloroquinoxaline) 是拓扑异构酶 II alpha/beta 毒物,具有抗肿瘤活性和免疫抑制特性,可抑制小鼠 B16 黑色素瘤细胞的增殖,可用于研究转移性结直肠癌。 | |||
T35300 |
Zeniplatin
Zeniplatinum |
Others | Others |
Zeniplatin (Zeniplatinum) 是一种新顺铂复合物,具有抗癌活性,可用于治疗转移性黑色素瘤和肾癌。 | |||
T9236 |
WSB1 Degrader 1
|
Others; E1/E2/E3 Enzyme | Others; Ubiquitination |
WSB1 Degrader 1 是具有口服活性的 WSB1降解剂,具有抗癌活性。 | |||
T62536 |
S100P-IN-1
|
Others | Others |
S100P-IN-1 是一种高效的 S100P 抑制剂。S100P-IN-1 对胰腺癌 (pancreatic) 细胞具有抗转移作用。 | |||
T21808 |
Inotilone
|
Others | Others |
Inotilone 是中药材 Inonotus linteus 的主要成分,可用于转移性肺癌细胞的研究。 | |||
T9075 |
BDP-13176
|
Others | Others |
BDP-13176 是fascin 1抑制剂,Kd=90 nM,IC50=240 nM。它具有成为抗转移剂的潜力。 | |||
T12433 |
PF-06952229
PF06952229 |
TGF-beta/Smad | Stem Cells |
PF-06952229 是 TGFβRI 的选择性抑制剂。 PF-06952229 可用于治疗实体瘤,特别是转移性乳腺癌的研究。 | |||
T27319 |
FIIN-4
FIIN4 |
FGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
FIIN-4 是 FGFR 的共价抑制剂,可用于转移性乳腺癌的研究。 | |||
T32427 |
KU-2285
KU2285,KU 2285 |
Others | Others |
KU-2285 对小鼠黑色素瘤 B16 显示出抗肿瘤、抗转移和抗集落形成作用。KU-2285 可用于研究胰腺癌。 | |||
T2113 |
PHA-793887
PHA 793887,PHA793887 |
Apoptosis; CDK | Apoptosis; Cell Cycle/Checkpoint |
PHA-793887 是一种ATP 竞争性的CDK 抑制剂,可抑制 Cdk2、Cdk1、Cdk4 和 Cdk9 的活性,IC50值分别为 8 nM、60 nM、62 nM 和 138 nM,同时可抑制糖原合酶激酶 3β,IC50值为 79 nM。 | |||
T17255 |
WJ460
|
Others | Others |
WJ460 是一种有效的肌铁蛋白抑制剂。 WJ460 在乳腺癌细胞中显示出抗转移活性。 | |||
T6215 |
Abiraterone Acetate
Zytiga,乙酸阿比特龙酯,CB7630 |
P450 | Metabolism |
Abiraterone Acetate (CB7630) 是一种具有口服活性的、不可逆的 CYP17A1选择性抑制剂,具有抗雄激素作用。它是 Abiraterone 的前药。 | |||
T76866 |
Icrucumab
LY 3012212,IMC-18F1 |
VEGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
Icrucumab ( IMC-18F1) 是一种人源化靶向血管内皮生长因子受体-1 的 IgG1 单克隆抗体。Icrucumab具有抗肿瘤活性,Icrucumab 具有研究转移性结肠癌。 | |||
T77138 |
Ragifilimab
INCAGN-01876,INCAGN-1876,CM-701 |
TNF | Apoptosis |
Ragifilimab (INCAGN-1876),一种针对糖皮质激素诱导的TNFR相关蛋白(GITR)的单克隆抗体激动剂,适用于晚期或转移性实体瘤的研究。 | |||
T22136 |
PRL-3 Inhibitor I
PRL-3 Inhibitor,BR-1 |
Phosphatase; Others | Metabolism; Others |
PRL-3 Inhibitor I (BR-1) 是 PRL-3 抑制剂,IC50=0.9 μM。它在细胞检测中显示降低侵袭性。 | |||
T2618 |
LGK974
LGK 974,LGK-974,NVP-LGK974,WNT974 |
Porcupine | Stem Cells |
LGK974 (NVP-LGK974) 是一种有效的、特异性的、具有口服活性的Porcupine(PORCN) 抑制剂(IC50:0.1 nM)。 | |||
T3710 |
XMD16-5
|
Tyrosinase; PPAR | DNA Damage/DNA Repair; Metabolism; Proteases/Proteasome |
XMD16-5 是TNK2抑制剂,对D163E 和R806Q 突变体的IC50值分别为16和77nM。 | |||
T2357 |
GSK1059615
GSK 1059615,GSK-1059615 |
Apoptosis; PI3K; mTOR | Apoptosis; PI3K/Akt/mTOR signaling |
GSK1059615 是一种 PI3Kα/β/δ/γ可逆的抑制剂,同时也抑制 mTOR,IC50值分别为 0.4 nM/0.6 nM/2 nM/5 nM 和 12 nM,已用于研究淋巴瘤、实体瘤、子宫内膜癌、实体瘤癌和转移性乳腺癌治疗的试验。 | |||
T39044 |
Rezvilutamide
SHR3680 |
Androgen Receptor | Endocrinology/Hormones |
Rezvilutamide (SHR3680)是一种可口服且可穿过血脑屏障的雄激素受体 (androgen receptor) 抑制剂,具有抗肿瘤活性。Rezvilutamide (SHR3680) 可用于研究转移性去势抵抗性前列腺癌。 | |||
T39403 |
Avotaciclib
BEY1107,Avotaciclib |
CDK | Cell Cycle/Checkpoint |
Avotaciclib (BEY1107) 是一种有效和具有口服活性的 cyclin dependent kinase 1 (CDK1) 抑制剂。Avotaciclib 可用于研究局部晚期或转移性胰腺癌。 | |||
T26969 |
CCT365623
CCT-365623,CCT 365623 |
Monoamine Oxidase | Neuroscience |
CCT365623 是一种口服生物可利用的赖氨酰氧化酶抑制剂,具有良好的抗 LOX 效力、选择性、药代动力学特性以及抗转移功效。 | |||
T0078 |
Lapatinib
GSK572016,GW572016,拉帕替尼 |
EGFR; Ferroptosis; Autophagy | Angiogenesis; Apoptosis; Autophagy; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Lapatinib (GW572016) 是一种 ErbB2 和 EGFR 的抑制剂 (IC50=9.2/10.8 nM),具有口服活性。Lapatinib 具有抗肿瘤活性,可以用于治疗 HER2 过表达的晚期或转移性乳腺癌。 | |||
T24644 |
Piritrexim
BW 301U |
DHFR | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Metabolism |
Piritrexim (BW 301U) 是一种可口服的脂溶性二氢叶酸还原酶抑制剂,具有肺毒性,用于研究尿路上皮癌和转移性乳腺癌。 | |||
T4022 |
QS11
QS 11 |
GTPase | GPCR/G Protein |
QS11 是一种ARFGAP1抑制剂(EC50:1.5 µM)。QS 11 能抑制 ARFGAP 过表达的乳腺癌细胞迁移。QS 11 通过影响蛋白质运输来增强 Wnt/β-catenin 信号。 | |||
T13688 |
Eribulin
ER-086526,E7389,B1939 |
Microtubule Associated; ADC Cytotoxin | Antibody-drug Conjugate/ADC Related; Cytoskeletal Signaling |
Eribulin (B1939) 是非紫杉烷微管动力学抑制剂,具有抗癌活性,通过防止细胞分裂过程中微管的延长和缩短来抑制微管蛋白亚基的聚合。Eribulin 可用于研究转移性乳腺癌和实体瘤。 | |||
T2381 |
Abemaciclib
CDK4/6 dual inhibitor,LY2835219 |
CDK | Cell Cycle/Checkpoint |
Abemaciclib (LY2835219) 是一种 CDK4/6 的双重抑制剂 (IC50=2/10 nM),具有选择性和特异性。Abemaciclib 具有抗肿瘤活性,被用于治疗晚期或转移性乳腺癌。 | |||
T36648 |
Tucatinib hemiethanolate
ONT-380 hemiethanolate,ARRY-380 hemiethanolate,Irbinitinib hemiethanolate |
HER | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Tucatinib hemiethanolate (Irbinitinib hemiethanolate) 是一种具有口服活性、选择性和高效性的靶向人表皮生长因子受体2(HER2)的酪氨酸激酶抑制剂,具有抗癌活性,可用于研究转移性HER2阳性乳腺癌和结直肠癌。 | |||
T77374 |
Ontuxizumab
MORAb-004 |
Others | Others |
Ontuxizumab (MORAb-004) 是一种靶向内髓酸的单克隆抗体,具有抗肿瘤作用。Ontuxizumab 是一种有效的 IgG1/κ 抗内皮素 (TEM-1 或 CD248) 的单克隆抗体,可用于治疗转移性黑色素瘤。 | |||
T76828 |
Sonepcizumab
LT 1009 |
LPL Receptor | GPCR/G Protein |
Sonepcizumab (LT 1009) 是一种完全人源化的抗 S1P 单克隆抗体。Sonepcizumab 具有抗癌活性,可用于研究转移性肾细胞癌 (mRCC) ,可预防青光眼滤过手术后的眼部瘢痕形成。 | |||
T76750 |
Cemiplimab
REGN-2810,SAR-439684 |
Others | Others |
Cemiplimab (Anti-Human PD-1) 是一种针对程序性细胞死亡受体 1 (PD-1) 的人单克隆抗体,也是一种检查点抑制剂,可阻断 PD-1/PD-L1 介导的 T 细胞抑制,可用于转移性癌症和鳞状细胞皮肤癌研究。 | |||
T76857 |
Anetumab
|
Others | Others |
Anetumab 是一种新型全人源抗间皮素 IgG1抗体,是 Anetumab ravtansine的裸抗。Anetumab 可用于合成抗体-活性分子偶联物 Anetumab ravtansine。Anetumab 可用于研究治疗转移性胸膜间皮瘤。 | |||
T29214 |
ZEN-3694
ZEN 3694,ZEN3694 |
Epigenetic Reader Domain | Chromatin/Epigenetic |
ZEN-3694 (ZEN 3694) 是一种溴结构域末端外抑制剂(BETi),在雄激素信号抑制剂(ASI)耐药模型中具有活性,可与恩杂鲁胺联合用于研究转移性去势抵抗性前列腺癌。 | |||
T76890 |
Petosemtamab
MCLA 158 |
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Petosemtamab (MCLA 158) 是一种高效的抗 EGFR (Kd: 0.22 nM) 和抗 LGR5 (Kd: 0.86 nM) 单克隆抗体。Petosemtamab 促使 LGR5+ 癌细胞中的 EGFR 信号传导中断和受体分解。Petosemtamab 可用于头颈部鳞状细胞癌 (HNSCC)、转移性结直肠癌 (CRC) 等实体瘤的研究。 | |||
T77149 |
Cobolimab
TSR-022,GSK4069889 |
Others | Others |
Cobolimab (TSR-022) 是一种有效的 TIM-3 单克隆抗体。Cobolimab 诱导 TIM-3 的内化,IC50 值为 0.4464 nM。Cobolimab 具有抗肿瘤活性,可用于研究晚期/转移性黑色素瘤和晚期肝细胞癌。 | |||
T60616 |
MPT0G211
|
HDAC | Chromatin/Epigenetic; DNA Damage/DNA Repair |
MPT0G211 是一种具有高效性选择性和口服活性的 HDAC6 抑制剂 (IC50=0.291 nM),具有神经保护作用在人乳腺癌细胞中显示出有抗转移活性。MPT0G211 对 HDAC6 的亲和力是其他 HDAC 亚型的 1000 倍。MPT0G211 可以透过血脑屏障,可用于改善阿尔茨海默病模型中 tau 磷酸化和认知缺陷。 | |||
T9912 |
Trastuzumab
|
EGFR; ADC Antibody | Angiogenesis; Antibody-drug Conjugate/ADC Related; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Trastuzumab 属于人源化单克隆抗体,可以高亲和力与 HER2 选择性结合。Trastuzumab 具有抗肿瘤活性,可用于治疗 HER2 阳性肿瘤。Trastuzumab 可以诱导细胞周期阻滞,介导细胞毒性,抑制 DNA 损伤修复。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T0934 |
Nicotinamide
Nicotinic acid amide,Vitamin B3,Niacinamide,烟酰胺,Vitamin PP |
Sirtuin; Endogenous Metabolite | Chromatin/Epigenetic; DNA Damage/DNA Repair; Metabolism |
Nicotinamide 是维生素 B3 的吡啶核苷形式,可作为烟酰胺腺嘌呤二核苷酸或 NAD+ 的前体,可通过膳食摄入来补充,能预防或治疗黑舌病和糙皮病。 | |||
T1135 |
Vitamin D3
维生素D3,Cholecalciferol,Colecalciferol |
Endogenous Metabolite | Metabolism |
Vitamin D3 (Cholecalciferol) 是维生素 D 的一种天然存在形式,代谢激活后可以诱导细胞分化和癌细胞增殖。 | |||
T2543 |
Cabazitaxel
XRP6258,卡巴他塞,RPR-116258A,TXD 258,taxoid XRP6258 |
Microtubule Associated; Autophagy | Autophagy; Cytoskeletal Signaling |
Cabazitaxel (taxoid XRP6258) 是一种紫杉烷类的抗肿瘤剂,可用于治疗多西他赛失败后的去势抵抗性转移性前列腺癌。 | |||
T5S0803 |
Columbamine
非洲防己碱,Columbamin,Dehydroisocorypalmine |
Others | Others |
Columbamine (Columbamin) 是一种从植物中提取的季异喹啉生物碱。 | |||
T7927 |
β-Ionone
乙位紫罗兰酮,β-紫罗兰酮,β-lonone |
Apoptosis; Others | Apoptosis; Others |
β-Ionone (β-lonone) 是β-类胡萝卜素的端环类似物,广泛存在于水果和蔬菜中,可有效诱导胃腺癌细胞 SGC7901 凋亡,具有抗增殖、抗转移和抗肿瘤作用。 | |||
T1082 |
Benzyl isothiocyanate
Benzoylthiocarbimide,苄基异硫氰酸酯,异硫氰酸苯甲酯,Isothiocyanic Acid Benzoyl Ester |
Apoptosis; Antibacterial; Antibiotic | Apoptosis; Microbiology/Virology |
Benzyl isothiocyanate (Benzoylthiocarbimide) 是一种具有杀菌活性的天然异硫氰酸酯,最初存在于十字花科蔬菜中。 它显示出免疫调节、抗寄生虫、抗生素、抗氧化、抗动脉粥样硬化、抗血管生成、抗转移、抗癌化疗和化学预防活性。 | |||
T20578 |
Maclurin
Fustic extract,Morintannic acid,NSC 83240 |
Free radical scavengers; Reactive Oxygen Species | Immunology/Inflammation; Metabolism; NF-κB; oxidation-reduction |
Maclurin (NSC-83240) 是桑枝的酚类成分,具有抗转移作用。 Maclurin 可有效防止 OH 诱导的 DNA 和 MSCs 损伤,可用于预防多种疾病或 MSCs 移植的研究。 | |||
T13741 |
Isoviolanthin
异佛莱心苷,异佛来心苷 |
Others | Others |
Isoviolanthin 是一种黄酮类苷类化合物,提取自铁皮石斛叶中。它能减少 TGF-β1 处理的 HCC 细胞的迁移和入侵能力,对正常细胞没有毒性影响,对转移性肝癌晚期具有潜在的研究价值。 | |||
T2P2923 |
Stearic acid
硬脂酸,Isostearic acid,Octadecanoic acid,Cetylacetic acid |
Phosphatase; Endogenous Metabolite | Metabolism |
Stearic acid (Cetylacetic acid) 是长链饱和脂肪酸,存在于许多动植物油脂中。 | |||
TN1013 |
Cucurbitacin D
|
Apoptosis | Apoptosis |
Cucurbitacin D 是一种从 Ecballium elaterium (L.)分离出来的三萜类化合物,具有抗癌抗肿瘤活性,抑制转移性 PrC 中的葡萄糖摄取和乳酸产生,诱导独立于 ERK1/2 激活的炎症小体激活。 Cucurbitacin D 是巨噬细胞中的一种新的炎症小体激活剂,通过调节 JAK/STAT3、PI3K/Akt/mTOR 和 MAPK 信号通路抑制 HepG2 细胞增殖并诱导细胞凋亡, 可用于研究宫颈癌、白血病和前列腺癌。 | |||
T5S2358 |
Dehydrocorydaline
Dehydrocorydalin,脱氢紫堇碱,13-Methylpalmatine |
BCL; PARP; p38 MAPK; Caspase; Parasite; Autophagy | Apoptosis; Autophagy; Chromatin/Epigenetic; DNA Damage/DNA Repair; MAPK; Microbiology/Virology; Proteases/Proteasome |
Dehydrocorydaline (13-Methylpalmatine) 是一种生物碱。它调节Bax,Bcl-2蛋白表达,激活caspase-7,caspase-8,并使PARP 失活。它能增强p38 MAPK 活化,具有抗炎、抗癌等功效。它具有强大的抗疟疾作用,并具低细胞毒性。 | |||
T6S1369 |
Vitexin
牡荆素,Apigenin-8-C-glucoside |
Antioxidant | oxidation-reduction |
Vitexin 是一种存在于多种药用植物(如榕树、螺旋藻)中的 c-糖基化的黄酮。 它具有广泛的药理作用,包括抗氧化,抗癌,抗炎,抗痛觉过敏和神经保护作用。 | |||
T5S0053 |
Coptisine
黄连碱,Coptisin |
Indoleamine 2,3-Dioxygenase (IDO) | Metabolism |
Coptisine (Coptisin) 是一种从黄连中分离到的生物碱,是非竞争性的IDO 抑制剂,Ki=为 5.8 μM,IC50=6.3 μM。 | |||
TN1867 |
Licoricidin
|
MMP; VEGFR; ROS | Angiogenesis; Immunology/Inflammation; Proteases/Proteasome; Tyrosine Kinase/Adaptors |
Licoricidin, is a potent anti-metastatic agent, which can markedly inhibit the metastatic and invasive capacity of malignant prostate cancer cells. | |||
T13472 |
α-Carotene
|
Others | Others |
α-Carotene is isolated from yellow-orange and dark-green vegetables. α-Carotene is used as an anti-metastatic agent or as an adjuvant for anti-cancer drugs. | |||
TN1062 |
Peonidin chloride
|
ERK; COX | Immunology/Inflammation; MAPK; Neuroscience |
Peonidin chloride has antioxidant activity. Peonidin has show potent inhibitory and apoptotic effects on cancer cells in vitro, notably metastatic human breast cancer cells. | |||
TN2813 |
23-deoxojessic acid
|
Others | Others |
23-Deoxojessic acid possesses strong cytotoxicity towards highly liver metastatic murine colon 26-L5 carcinoma cells, with ED50 values equal to or less than 6 microM. | |||
T16035 |
Meleagrin
|
Others | Others |
Meleagrin, a roquefortine C-derived alkaloid produced by Penicillium fungi, serves as both a class of FabI inhibitors and a lead c-Met inhibitory entity for controlling c-Met-dependent metastatic and invasive breast malignancies. It exhibits antimicrobial and anti-proliferative activities. | |||
TN3517 |
Bisacurone
|
IL Receptor; IκB/IKK; TNF; NF-κB; ROS; Akt; PKC | Apoptosis; Chromatin/Epigenetic; Cytoskeletal Signaling; Immunology/Inflammation; NF-κB; PI3K/Akt/mTOR signaling |
Bisacurone has anti-oxidant, anti-inflammatory, and anti-metastatic activities, it may have a protective effect against ethanol-induced liver injury by suppressing hepatic oxidation and inflammation. | |||
TN4352 |
Jatamanvaltrate B
|
Others | Others |
Jatamanvaltrate B shows cytotoxicity against lung adenocarcinoma (A549), metastatic prostate cancer (PC-3M), colon cancer (HCT-8),and hepatoma (Bel7402) cell lines. | |||
TN4101 |
Ganoderenic acid H
|
Others | Others |
Ganoderenic acid H is one compound of triterpenoids isolated from Ganoderma lucidum, triterpenoids exhibit a broad spectrum of anti-cancer properties, including anti-proliferative, anti-metastatic and anti-angiogenic activities. | |||
TN3646 |
Chlorovaltrate K
|
Others | Others |
Chlorovaltrate K shows moderate cytotoxicity against lung adenocarcinoma (A 549), metastatic prostate cancer (PC-3M), colon cancer (HCT-8) and hepatoma (Bel 7402) cell lines with IC50 values of 0.89-9.76 uM. | |||
TN5249 |
Volvaltrate B
|
Others | Others |
Volvaltrate B shows cytotoxic activity against the lung adenocarcinoma (A549), metastatic prostate cancer (PC-3M), colon cancer (HCT-8), and hepatoma (Bel7402) cell lines, with IC50 values of 8.5, 2.0, 3.2, and 6.1 uM, respectively. | |||
T37055 |
Cytostatin
|
Others | Others |
Cytostatin is a natural antitumor inhibitor of cell adhesion to extracellular matrix, blocking adhesion of B16 melanoma cells to laminin and collagen type IV in vitro (IC50s = 1.3 and 1.4 μg/ml, respectively) and B16 cells metastatic activity in mice. It induces apoptosis of FS3 mouse fibrosarcoma cells (IC50 = 3.1 μg/ml). Cytostatin potently and selectively inhibits protein phosphatase 2A (PP2A; IC50 = 29 nM against the catalytic subunit), while having no effect against PP1, PP2B, or PP5. | |||
TN4046 |
Excisanin A
|
MMP; FAK; PARP; GSK-3; NF-κB; Wnt/beta-catenin; Akt; Caspase; PI3K; Prostaglandin Receptor; JNK | Angiogenesis; Apoptosis; Chromatin/Epigenetic; Cytoskeletal Signaling; DNA Damage/DNA Repair; GPCR/G Protein; Immunology/Inflammation; MAPK; NF-κB; PI3K/Akt/mTOR signaling; Proteases/Proteasome; Stem Cells; Tyrosine Kinase/Adaptors |
ExcisaninA may be a potent inhibitor of AKT signaling pathway in tumor cells, it can inhibit invasion by suppressing MMP-2 and MMP-9 expression, it may be a potential anti-metastatic chemotherapeutic agent for the treatment of breast cancer. Excisanin A shows comparable inhibitory effects on the LPS-induced production of NO and PGE2, and activation of NF-kappaB without affecting cell viability.Excisanin A induces apoptosis in colon cancer cell line SW620 as determined by Annexin V staining, the ... | |||
T40960 |
Fibronectin
|
Integrin | Cytoskeletal Signaling |
Fibronectin 是存在于血液、结缔组织和细胞表面中的高分子糖蛋白,可作为组织损伤的生物标记物。Fibronectin 可被整合素家族表面受体识别。Fibronectin 可用于研究原发性开角型青光眼。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPH-00003 |
LASP1 Protein, Human, Recombinant (His)
LIM and SH3 domain protein 1,Metastatic lymph node ... |
Human | P. pastoris (Yeast) |
LASP1 Protein, Human, Recombinant (His) is expressed in yeast with C-6xHis tag. The predicted molecular weight is 31.2 kDa; 43 kDa, reducing conditions and the accession number is Q14847. | |||
TMPJ-00778 |
HER2/ERBB2 Protein, Human, Recombinant (His)
TKR1,Metastatic lymph node gene 19 protein,ERBB2,Pr... |
Human | HEK293 Cells |
HER2/ERBB2 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with C-6xHis tag. The predicted molecular weight is 90-120 KDa and the accession number is P04626. | |||
TMPJ-00776 |
HER2/ERBB2 Protein, Human, Recombinant (hFc & Avi), Biotinylated
Tyrosine kinase-type cell surface receptor HER2,NGL,EGFR2,TK... |
Human | HEK293 Cells |
HER2/ERBB2 Protein, Human, Recombinant (hFc & Avi), Biotinylated is expressed in HEK293 mammalian cells with C-Fc-Avi tag. The predicted molecular weight is 120-140 KDa and the accession number is P04626. | |||
TMPJ-00777 |
HER2/ERBB2 Protein, Human, Recombinant (aa 23-652, hFc)
TKR1,Proto-oncogene Neu,EGFR2,Tyrosine kinase-type cell surf... |
Human | HEK293 Cells |
HER2/ERBB2 Protein, Human, Recombinant (aa 23-652, hFc) is expressed in HEK293 mammalian cells with C-Fc tag. The predicted molecular weight is 120-145 KDa and the accession number is P04626. | |||
TMPY-02030 |
CD82 Protein, Human, Recombinant (His)
CD82 molecule,SAR2,R2,KAI-1,4F9,KAI1,C33,TSPAN27,ST6,IA4,GR1... |
Human | HEK293 Cells |
CD82, also known as KAI-1, structurally belongs to tetraspanin family while categorised as metastasis suppressor gene on functional grounds. KAI1/CD82 is localized on cell membrane and form interactions with other tetraspanins, integrins and chemokines which are respectively responsible for cell migration, adhesion and signalling. Downregulation of CD82 expression is associated with the advanced stages of many human cancers and correlates with the acquisition of metastatic potential. Recent stud... | |||
TMPY-04722 |
DcR1/TRAILR3 Protein, Human, Recombinant (His)
TRAILR3,TRID,DCR1,TRAIL-R3,CD263,DCR1-TNFR,tumor necrosis fa... |
Human | HEK293 Cells |
TNFRSF10C CNV in patients with CRC is associated with distant metastatic disease. A high frequency of CGI methylation in the TNFRSF10C promoter results in inactivation of the gene and enhancement of tumor growth in most PC cell lines (except CFPAC-1). Inactivation of TNFRSF10C by CpG island (CGI) hypermethylation can play an important role in PC progression and be potentially useful as a diagnostic marker and a new therapeutic approach for PC. | |||
TMPY-04830 |
GAS6 Protein, Mouse, Recombinant (His)
growth arrest-specific 6,Gas-6 |
Mouse | HEK293 Cells |
The growth arrest-specific 6 gene (GAS6) is a member of the family of plasma vitamin K-dependent proteins, which are able to bind to phospholipids using an N-terminal gamma-carboxyglutamic acid domain. GAS6 is a vitamin K-dependent protein, plays a role in the survival, proliferation, migration, differentiation, adhesion, and apoptosis of cells. The growth arrest-specific 6 (GAS6) has been implicated in systemic inflammation and coagulation. Growth arrest-specific 6 (GAS6), plays a role in tumor... | |||
TMPK-01299 |
CEACAM5 Protein, Cynomolgus, Recombinant (aa 35-685, His)
Carcinoembryonic,CEA,CEACD66e,DKFZp781M2392,CEACAM-5,CD66e,M... |
Cynomolgus | HEK293 Cells |
Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5) was identified as a metastatic driver. CEACAM5 overproduction enriched for an epithelial gene expression pattern and facilitated tumor outgrowth at metastatic sites. Tissues from patients with metastatic breast cancer confirmed elevated levels of CEACAM5 in lung metastases relative to breast tumors, and an inverse correlation between CEACAM5 and the mesenchymal marker vimentin was demonstrated. | |||
TMPY-03876 |
PTGFRN Protein, Cynomolgus, Recombinant (His)
prostaglandin F2 receptor inhibitor |
Cynomolgus | HEK293 Cells |
EWI-F, also known as PTGFRN, is inversely related to the loss of CD9. Its expression correlates with the metastatic status of hLT. EWI-F inhibits the binding of prostaglandin F2-alpha (PGF2-alpha) to its specific FP receptor, by decreasing the receptor number rather than the affinity constant. EWI-F expression positively correlates with the metastatic status of hLT, and that the upregulation of EWI-F expression could be one of the mechanisms underlying the loss of CD9 in solid tumours. | |||
TMPY-02622 |
Aldolase B Protein, Human, Recombinant (GST)
aldolase B, fructose-bisphosphate,ALDO2,ALDB |
Human | E. coli |
The aldolase family members involved in metabolism and glycolysis are present in three isoforms: ALDOA, ALDOB, and ALDOC. Aldolases are differentially expressed in human tissues, and aberrant expression has been observed in several human diseases and cancer types. Via GATA6, metastatic cells in the liver upregulate the enzyme aldolase B (ALDOB), which enhances fructose metabolism and provides fuel for major pathways of central carbon metabolism during tumor cell proliferation. Targeting ALDOB or... | |||
TMPY-01122 |
CGB5 Protein, Human, Recombinant (mFc)
HCG,hCGB,chorionic gonadotropin beta subunit 5,chorionic gon... |
Human | HEK293 Cells |
The human CGB5 gene encodes chorionic gonadotropin (hCG)beta 5, which is aberrantly expressed in trophoblastic neoplasm and in some non-trophoblastic neoplasms. Fucntional studies observed that it involved tumor initiation, growth, and metastatic outgrowth. Carriage of particular variants in the promoter of the CGB5 gene seems to protect against RM. CGB5 Protein, Human, Recombinant (mFc) is expressed in HEK293 mammalian cells with mFc tag. The predicted molecular weight is 41.9 kDa and the acces... | |||
TMPK-01182 |
CDCP1 Protein, Human, Recombinant (hFc)
CDCP1,PRO5773,TRASK,UNQ2486,SIMA135,CD318 |
Human | HEK293 Cells |
Tumor metastasis depends on the dynamic regulation of cell adhesion through β1-integrin. The Cub-Domain Containing Protein-1, CDCP1, is a transmembrane glycoprotein which regulates cell adhesion. Overexpression and loss of CDCP1 have been observed in the same cancer types to promote metastatic progression. CDCP1 Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with C-hFc tag. The predicted molecular weight is 98.4 kDa and the accession number is Q9H5V8-1. | |||
TMPK-01181 |
CDCP1 Protein, Human, Recombinant (His & Avi), Biotinylated
CDCP1,PRO5773,TRASK,UNQ2486,SIMA135,CD318 |
Human | HEK293 Cells |
Tumor metastasis depends on the dynamic regulation of cell adhesion through β1-integrin. The Cub-Domain Containing Protein-1, CDCP1, is a transmembrane glycoprotein which regulates cell adhesion. Overexpression and loss of CDCP1 have been observed in the same cancer types to promote metastatic progression. CDCP1 Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with C-His-Avi tag. The predicted molecular weight is 74.6 kDa and the accession number is Q9... | |||
TMPK-01255 |
CDCP1 Protein, Cynomolgus, Recombinant (His & Avi), Biotinylated
TRASK,SIMA135,UNQ2486,PRO5773,CD318,CDCP1 |
Cynomolgus | HEK293 Cells |
Tumor metastasis depends on the dynamic regulation of cell adhesion through β1-integrin. The Cub-Domain Containing Protein-1, CDCP1, is a transmembrane glycoprotein which regulates cell adhesion. Overexpression and loss of CDCP1 have been observed in the same cancer types to promote metastatic progression. CDCP1 Protein, Cynomolgus, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with C-His-Avi tag. The predicted molecular weight is 75 kDa and the accession number is... | |||
TMPY-05250 |
CLEC3A Protein, Mouse, Recombinant (His)
C-type lectin domain family 3, member A,Gm796,1110019O10Rik,... |
Mouse | Baculovirus Insect Cells |
C-type lectin domain family 3 member A (CLEC3A) is a poorly characterized protein belonging to the superfamily of C-type lectins. Elevated CLEC3A expression may correlate with breast IDC metastatic potential and indicated a poor prognosis in breast IDC. CLEC3A knockdown inhibited BC cell growth and metastasis might be through suppressing PI3K/AKT signaling activity. That CLEC3A is a promising therapeutic target for BC in the future. Matrilysin (MMP-7) plays important roles in tumor progression. ... | |||
TMPK-00593 |
Syndecan-1 Protein, Human, Recombinant (His & Avi), Biotinylated
Syndecan-1,CD138,SDC1,SYND1,SDC |
Human | HEK293 Cells |
Liver diseases such as liver cirrhosis, primary and metastatic liver cancers are still a major medical challenge. Syndecan-1 is one of the most important proteoglycans in the liver. Syndecan-1 is normally expressed on the surfaces of hepatocytes and cholangiocytes. Due to liver diseases the amount of syndecan-1 increases in the liver. Syndecan-1 Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with C-His-Avi tag. The predicted molecular weight is 26.8 ... | |||
TMPK-00635 |
CDCP1 Protein, Rat, Recombinant (His)
TRASK,SIMA135,UNQ2486,CD318,PRO5773,CDCP1 |
Rat | HEK293 Cells |
Tumor metastasis depends on the dynamic regulation of cell adhesion through β1-integrin. The Cub-Domain Containing Protein-1, CDCP1, is a transmembrane glycoprotein which regulates cell adhesion. Overexpression and loss of CDCP1 have been observed in the same cancer types to promote metastatic progression. CDCP1 Protein, Rat, Recombinant (His) is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 73.09 kDa and the accession number is D3ZVA1. | |||
TMPK-01256 |
CDCP1 Protein, Cynomolgus, Recombinant (His)
TRASK,SIMA135,UNQ2486,CD318,PRO5773,CDCP1 |
Cynomolgus | HEK293 Cells |
Tumor metastasis depends on the dynamic regulation of cell adhesion through β1-integrin. The Cub-Domain Containing Protein-1, CDCP1, is a transmembrane glycoprotein which regulates cell adhesion. Overexpression and loss of CDCP1 have been observed in the same cancer types to promote metastatic progression. CDCP1 Protein, Cynomolgus, Recombinant (His) is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 73.2 kDa and the accession number is F6TPM5. | |||
TMPK-00595 |
Syndecan-1 Protein, Human, Recombinant (aa 23-254, His)
Syndecan-1,CD138,SDC,SYND1,SDC1 |
Human | HEK293 Cells |
Liver diseases such as liver cirrhosis, primary and metastatic liver cancers are still a major medical challenge. Syndecan-1 is one of the most important proteoglycans in the liver. Syndecan-1 is normally expressed on the surfaces of hepatocytes and cholangiocytes. Due to liver diseases the amount of syndecan-1 increases in the liver. Syndecan-1 Protein, Human, Recombinant (aa 23-254, His) is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 25 kDa and the acc... | |||
TMPJ-00786 |
ITGB1 Protein, Human, Recombinant (aa 21-728, His)
Integrin Beta-1,VLA-4 Subunit β,Fibronectin Receptor Subunit... |
Human | HEK293 Cells |
Integrin β-1 (ITGB1) belongs to the integrin β chain family. Integrin family members are membrane receptors involved in cell adhesion and recognition in a variety of processes including embryogenesis, hemostasis, tissue repair, immune response and metastatic diffusion of tumor cells. ITGB1 is an integrin unit associated with very late antigen receptors, which contains one VWFA domain. It is known to conjoin with α-3 subunit to create α3β1 complex that reacts to such molecules as netrin-1 and ree... | |||
TMPK-01010 |
CDCP1 Protein, Mouse, Recombinant (His & Avi), Biotinylated
UNQ2486,TRASK,CD318,SIMA135,CDCP1,PRO5773 |
Mouse | HEK293 Cells |
Tumor metastasis depends on the dynamic regulation of cell adhesion through β1-integrin. The Cub-Domain Containing Protein-1, CDCP1, is a transmembrane glycoprotein which regulates cell adhesion. Overexpression and loss of CDCP1 have been observed in the same cancer types to promote metastatic progression. CDCP1 Protein, Mouse, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with C-His-Avi tag. The predicted molecular weight is 75.3 kDa and the accession number is Q5... | |||
TMPK-01183 |
CDCP1 Protein, Human, Recombinant (aa 30-368, His)
CDCP1,PRO5773,TRASK,CD318,UNQ2486,SIMA135 |
Human | HEK293 Cells |
Tumor metastasis depends on the dynamic regulation of cell adhesion through β1-integrin. The Cub-Domain Containing Protein-1, CDCP1, is a transmembrane glycoprotein which regulates cell adhesion. Overexpression and loss of CDCP1 have been observed in the same cancer types to promote metastatic progression. CDCP1 Protein, Human, Recombinant (aa 30-368, His) is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 39.03 kDa and the accession number is Q9H5V8-1. | |||
TMPY-02384 |
MTSS1 Protein, Human, Recombinant (aa1-250, His & MBP)
metastasis suppressor 1,MIMB,MIM,MIMA |
Human | E. coli |
MTSS1 (Metastasis suppressor 1), also known as Missing in metastasis (MIM), is a tissue-specific regulator of plasma membrane dynamics. MTSS1 is well described for its function as a metastasis suppressor gene and is expressed in a variety of tissues. MTSS1 might be involved in shaping neuronal membranes in vivo. MTSS1 deforms phosphoinositide-rich membranes through its I-BAR domain and interacts with actin monomers through its WH2 domain. MTSS1/MIM was first identified as a metastasis suppressor... | |||
TMPK-01284 |
Syndecan-1 Protein, Cynomolgus, Recombinant (His)
Syndecan-1,SYND1,SDC1,CD138,SDC |
Cynomolgus | HEK293 Cells |
Liver diseases such as liver cirrhosis, primary and metastatic liver cancers are still a major medical challenge. Syndecan-1 is one of the most important proteoglycans in the liver. Syndecan-1 is normally expressed on the surfaces of hepatocytes and cholangiocytes. Due to liver diseases the amount of syndecan-1 increases in the liver. Syndecan-1 Protein, Cynomolgus, Recombinant (His) is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 24.97 kDa and the access... | |||
TMPY-03982 |
CGB5 Protein, Human, Recombinant (His)
chorionic gonadotropin beta subunit 5,HCG,chorionic gonadotr... |
Human | HEK293 Cells |
The human CGB5 gene encodes chorionic gonadotropin (hCG)beta 5, which is aberrantly expressed in trophoblastic neoplasm and in some non-trophoblastic neoplasms. Fucntional studies observed that it involved tumor initiation, growth, and metastatic outgrowth. Carriage of particular variants in the promoter of the CGB5 gene seems to protect against RM. CGB5 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 17 kDa and the accessi... | |||
TMPK-00594 |
Syndecan-1 Protein, Human, Recombinant (aa 23-254, hFc)
CD138,SDC1,SYND1,Syndecan-1,SDC |
Human | HEK293 Cells |
Liver diseases such as liver cirrhosis, primary and metastatic liver cancers are still a major medical challenge. Syndecan-1 is one of the most important proteoglycans in the liver. Syndecan-1 is normally expressed on the surfaces of hepatocytes and cholangiocytes. Due to liver diseases the amount of syndecan-1 increases in the liver. Syndecan-1 Protein, Human, Recombinant (aa 23-254, hFc) is expressed in HEK293 mammalian cells with C-hFc tag. The predicted molecular weight is 50.6 kDa and the a... | |||
TMPK-00201 |
Syndecan-1 Protein, Mouse, Recombinant (hFc)
Syndecan-1,CD138,SDC,SDC1,SYND1 |
Mouse | HEK293 Cells |
Liver diseases such as liver cirrhosis, primary and metastatic liver cancers are still a major medical challenge. Syndecan-1 is one of the most important proteoglycans in the liver. Syndecan-1 is normally expressed on the surfaces of hepatocytes and cholangiocytes. Due to liver diseases the amount of syndecan-1 increases in the liver. Syndecan-1 Protein, Mouse, Recombinant (hFc) is expressed in HEK293 mammalian cells with C-hFc tag. The predicted molecular weight is 51 kDa and the accession numb... | |||
TMPK-00906 |
PSCA Protein, Mouse, Recombinant (hFc)
UNQ206,PSCA,PRO232 |
Mouse | HEK293 Cells |
Gastric cancer is a deadly malignancy and is a prognostically unfavorable entity with restricted therapeutic strategies available. Prostate stem cell antigen (PSCA) is a glycosylphosphatidylinositol (GPI)-anchored cell surface protein widely expressed in bladder, prostate, and pancreatic cancers. Existing studies have thoroughly recognized the availability of utilizing anti-PSCA CAR-T cells in the treatment of metastatic prostate cancer and non-small-cell lung cancer. PSCA Protein, Mouse, Recomb... | |||
TMPK-00728 |
PSCA Protein, Human, Recombinant (hFc)
UNQ206,PRO232,PSCA |
Human | HEK293 Cells |
Gastric cancer is a deadly malignancy and is a prognostically unfavorable entity with restricted therapeutic strategies available. Prostate stem cell antigen (PSCA) is a glycosylphosphatidylinositol (GPI)-anchored cell surface protein widely expressed in bladder, prostate, and pancreatic cancers. Existing studies have thoroughly recognized the availability of utilizing anti-PSCA CAR-T cells in the treatment of metastatic prostate cancer and non-small-cell lung cancer. PSCA Protein, Human, Recomb... | |||
TMPY-03047 |
Stathmin 1 Protein, Human, Recombinant (His)
SMN,OP18,stathmin 1,LAP18,C1orf215,PP17,Lag,PP19,PR22 |
Human | E. coli |
Stathmin1 (STMN1) is a cytosolic phosphoprotein that regulates cellular microtubule dynamics and is known to have oncogenic activity. STMN1 is a possible biomarker for paclitaxel sensitivity and poor prognosis in GC and could be a novel therapeutic target in metastatic GC. STMN1 expression might serve as a biomarker for determining patient atypical meningioma prognosis. Stathmin1 (STMN1) is a cytosolic protein involved in microtubule dynamics through inhibition of tubulin polymerization and prom... | |||
TMPY-04765 |
PKLR Protein, Human, Recombinant (His)
PKRL,PKR,RPK,PKL,PK1,pyruvate kinase, liver and RBC |
Human | E. coli |
Pyruvate kinase (PKLR) is a critical erythrocyte enzyme that is required for glycolysis and production of ATP. Pyruvate kinase deficiency (PKD) is the most frequent red blood cell enzyme abnormality of the glycolytic pathway and the most common cause of hereditary nonspherocytic hemolytic anemia. Over 250 PKLR-gene mutations have been described, including missense/nonsense, splicing and regulatory mutations, small insertions, small and gross deletions, causing PKD and hemolytic anemia of variabl... | |||
TMPY-04203 |
RAB1B Protein, Human, Recombinant (hFc)
RAB1B, member RAS oncogene family |
Human | HEK293 Cells |
RAB1B, a member of the RAS oncogene family, was significantly down-regulated in highly metastatic breast cancer cells. Moreover, down-regulation of RAB1B was also found to promote the proliferation and migration of TNBC cells in vitro and in vivo. Mechanistically, loss of RAB1B resulted in elevated expression of TGF-beta receptor 1 (TbetaR1) through decreased degradation of ubiquitin, increased levels of phosphorylated SMAD3 and TGF-beta-induced epithelial-mesenchymal transition (EMT). Furthermo... | |||
TMPJ-00157 |
CD82 Protein, Human, Recombinant (hFc)
Tetraspanin-27,KAI1,ST6,TSPAN27,TSPAN274F9,CD82 molecule,Tsp... |
Human | HEK293 Cells |
CD82 antigen, also known as Kai-1, is a widely expressed palmitoylated molecule of the tetraspanin superfamily. KAI1/CD82 is localized on cell membrane and form interactions with other tetraspanins, integrins and chemokines which are respectively responsible for cell migration, adhesion and signaling. CD82/Kai-1 is a component of the promiscuous TIMP-1 interacting protein complex on the cell surface of human adenocarcinoma cells and gives insight into tumorigenic metastatic potential. CD82/Kai-1... | |||
TMPY-02276 |
GPR56 Protein, Human, Recombinant (His)
BFPP,UNQ540/PRO1083,DKFZp781L1398,TM7LN4,adhesion G protein-... |
Human | HEK293 Cells |
ADGRG1 (Adhesion G Protein-Coupled Receptor G1, also known as GPR56) is a Protein Coding gene. GPR56 is a member of an adhesion G protein-coupled receptor family with a very long N-terminal stalk and seven transmembrane domains. The encoded protein binds specifically to transglutaminase 2, a component of tissue and tumor stroma implicated as an inhibitor of tumor progression. GPR56 may be a target for the treatment of type 2 diabetes. GPR56 inhibits melanoma metastatic growth by impeding the exp... | |||
TMPJ-01137 |
MIA Protein, Human, Recombinant (His)
MIA,Melanoma Inhibitory Activity Protein,Melanoma-Derived Gr... |
Human | E. coli |
Melanoma Inhibitory Activity Protein (MIA) is an autocrine growth regulatory protein secreted from chondrocytes and malignant melanoma cells, which was the first discovered member of a family of secreted cytokines termed the MIA/OTOR family. The four known members of this family: MIA, MIA2, OTOR and TANGO each contain a Src homology-3 (SH3)-like domain. MIA acts as a potent tumor cell growth inhibitor for malignant melanoma cells and some other neuroectodermal tumors, including gliomas, in an au... | |||
TMPY-01595 |
PCBP1 Protein, Human, Recombinant (His)
HNRPE1,hnRNP-E1,HEL-S-85,HNRPX,poly(rC) binding protein 1,hn... |
Human | E. coli |
Poly(rC)-binding protein 1, also known as Heterogeneous nuclear ribonucleoprotein E1, Alpha-CP1, Nucleic acid-binding protein SUB2.3 and PCBP1, is a family member of heterogeneous nuclear ribonucleoproteins (hnRNPs) that belong to RNA-binding proteins and bear three KH domains. PCBP1 is loosely bound in the nucleus. It may shuttle between the nucleus and the cytoplasm. It is abundantly expressed in skeletal muscle, thymus and peripheral blood leukocytes while a lower expression is observed in pr... | |||
TMPY-02386 |
PTP4A2 Protein, Human, Recombinant (GST)
HNMT-S2,PRL-2,HNMT-S1,protein tyrosine phosphatase type IVA,... |
Human | E. coli |
PRL-2 (Protein-tyrosine phosphatase of regenerating liver 2), also known as PTP4A2 (Protein tyrosine phosphatase type IVA, member 2), is a member of PTP family and has an important function in controlling cell growth. PRL-2 phosphatases may be multifunctional enzymes with diverse roles in a variety of tissue and cell types. The phosphatase of regenerating liver (PRL) family, comprising PRL-1, PRL-2 and PRL-3, is a group of prenylated phosphatases that are candidate cancer biomarkers and therapeu... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TMID-0178 |
Stearic acid-18,18,18-d3
|
||
Stearic acid-18,18,18-d3 是 Stearic acid 的氘代化合物。Stearic acid 的 CAS 号为 57-11-4。Stearic acid是长链饱和脂肪酸,存在于许多动植物油脂中。 |